“The true strength of the AGITG has been its membership who have selflessly collaborated with the combined purpose to improve outcomes for people with GI cancer. The group is truly multidisciplinary and over the AGITG’s development its really gratifying to also see the consumer membership increase and contribute so well. Through the AGITG I have been privileged to work with so many world-class colleagues and look forward to the group’s next 25 years of fighting GI cancer”
Professor Michael Findlay held the role of Deputy Chairman of the AGITG from 2004 until 2016. He continues as a member of the AGITG Scientific Advisory Committee and Upper GI Cancer Working Party.
Michael graduated from the Otago University School of Medicine in 1983. He went on to specialise in medical oncology and was granted entry to the Fellowship of the Royal Australasian College of Physicians in 1990.
He began research into gastro-intestinal cancers at the Royal Marsden Hospital in London and completed the degree of Doctor of Medicine.
He became an active member of the AGITG with his appointment at Sydney Cancer Centre in 1994 and has remained active through positions at Wellington Cancer Centre and then as Professor of Oncology at the University of Auckland.
Michael is an advocate for research-driven cancer care and with his appointment in Auckland established Cancer Trials New Zealand. The organisation coordinates clinical trials and is involved in the design and conduct of clinical and translational trials across a wide range of cancer types. The aim of the group is to facilitate greater collaboration between New Zealand scientists and clinicians.
In addition to his University appointment he is Clinical Director Research, Regional Cancer & Blood Service, Auckland District Health Board, is a foundation director of the not-for-profit Gastro-Intestinal Cancer Institute (New Zealand) and a board member of the New Zealand Cancer Society (Northland and Auckland).